{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:25:07Z","timestamp":1774326307141,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T00:00:00Z","timestamp":1338595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00228-012-1311-9","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T00:24:22Z","timestamp":1341879862000},"page":"43-52","source":"Crossref","is-referenced-by-count":17,"title":["Population pharmacokinetics of lamotrigine in Indian epileptic patients"],"prefix":"10.1007","volume":"69","author":[{"given":"Surulivelrajan","family":"Mallaysamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma G. M.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiyagu","family":"Rajakannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh","family":"Bathala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan G. C.","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devarakonda","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,2]]},"reference":[{"issue":"1","key":"1311_CR1","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1177\/0883073897012001111","volume":"12","author":"JM Pellock","year":"1997","unstructured":"Pellock JM (1997) Overview of lamotrigine and the new antiepileptic drugs: the challenge. J Child Neurol 12(1):S48\u2013S52","journal-title":"J Child Neurol"},{"key":"1311_CR2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","volume":"27","author":"M Leach","year":"1986","unstructured":"Leach M, Marden C, Miller A (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II: neuronal studies on the mechanism of action. Epilepsia 27:490\u2013497","journal-title":"Epilepsia"},{"key":"1311_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","volume":"13","author":"H Cheung","year":"1992","unstructured":"Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107\u2013112","journal-title":"Epilepsy Res"},{"issue":"4","key":"1311_CR4","first-page":"54","volume":"7","author":"M Avoli","year":"1997","unstructured":"Avoli M (1997) Molecular mechanisms of antiepileptic drugs. Sci Am Sci Med 7(4):54\u201363","journal-title":"Sci Am Sci Med"},{"key":"1311_CR5","unstructured":"Lamictal Product Monograph. GlaxoSmithKline.RL-2370.2011. http:\/\/us.gsk.com\/products\/assets\/us_lamictal.pdf . Accessed 1 December 2011"},{"key":"1311_CR6","first-page":"659","volume":"121","author":"C Sharma","year":"2005","unstructured":"Sharma C, Dubey R, Kumar H, Saha N (2005) Food reduces the bioavailability of lamotrigine. Ind J Med Res 121:659\u2013664","journal-title":"Ind J Med Res"},{"issue":"1","key":"1311_CR7","first-page":"149","volume":"19","author":"MW Sinz","year":"1991","unstructured":"Sinz MW, Remmel RP (1991) Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine. Drug Metab Dispos 19(1):149\u2013153","journal-title":"Drug Metab Dispos"},{"key":"1311_CR8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17332","volume":"32","author":"GD Anderson","year":"1998","unstructured":"Anderson GD (1998) A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 32:554\u2013563","journal-title":"Ann Pharmacother"},{"key":"1311_CR9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","volume":"8","author":"IJ Svein","year":"2010","unstructured":"Svein IJ, Cecilie JL (2010) Antiepileptic drug interactions\u2014principles and clinical implications. Curr Neuropharmacol 8:254\u2013267","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1311_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","volume":"10","author":"JL Cecilie","year":"2010","unstructured":"Cecilie JL, Philip NP (2010) Drug interactions involving second and third generation antiepileptic drugs. Expert Rev Neurother 10(1):119\u2013140","journal-title":"Expert Rev Neurother"},{"key":"1311_CR11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","volume":"62","author":"AB David","year":"2005","unstructured":"David AB, Richard B, Stanley RR, Lawrence JH (2005) Effect of antiepileptic drug comedication on lamotrigine clearance. Arch Neurol 62:1432\u20131436","journal-title":"Arch Neurol"},{"issue":"121","key":"1311_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5414\/CPP47752","volume":"47","author":"JR Milovanovic","year":"2009","unstructured":"Milovanovic JR, Jankovic SM (2009) Population pharmacokinetics of lamotrigine in patients with epilepsy. Int J Clin Pharmacol Ther 47(121):752\u2013760","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1311_CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FTD.0b013e31817fd4d4","volume":"30","author":"N Rivas","year":"2008","unstructured":"Rivas N, Buelga DS, Elger CE, Santos-Borbujo J, Dom\u00ednguez-Gil MA, Garc\u00eda MJ (2008) Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy. Ther Drug Monit 30:483\u2013489","journal-title":"Ther Drug Monit"},{"key":"1311_CR14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0091270007313391","volume":"48","author":"B Punyawudho","year":"2008","unstructured":"Punyawudho B, Ramsay ER, Macias FM, Rowan JA, Collins JF, Brundage RC, Birbaum AK (2008) Population pharmacokinetics of lamotrigine in the elderly. J Clin Pharmacol 48:455\u2013463","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"1311_CR15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00007691-200112000-00006","volume":"23","author":"V Chan","year":"2001","unstructured":"Chan V, Morris RG, Ilett KF, Tett SE (2001) Population pharmacokinetics of lamotrigine. Ther Drug Monit 23(6):630\u2013635","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1311_CR16","first-page":"105","volume":"10","author":"S Zhang","year":"2008","unstructured":"Zhang S, Wang L, Lu W (2008) Population pharmacokinetics of lamotrigine in Chinese children with epilepsy. Zhongguo Dang DaiEr Ke Za Zhi 10(2):105\u2013109","journal-title":"Zhongguo Dang DaiEr Ke Za Zhi"},{"key":"1311_CR17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/00912709922007949","volume":"39","author":"TH Grasela","year":"1999","unstructured":"Grasela TH, Fiedler-Kelly J, Cox E, Womble GP, Risner ME, Chen C (1999) Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. J Clin Pharmacol 39:373\u2013384","journal-title":"J Clin Pharmacol"},{"key":"1311_CR18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2125.1997.00594.x","volume":"43","author":"Z Hussein","year":"1997","unstructured":"Hussein Z, Posner J (1997) Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 43:457\u2013465","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1311_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1528-1157.1999.tb05566.x","volume":"40","author":"R Sridharan","year":"1999","unstructured":"Sridharan R, Murthy BN (1999) Prevalence and pattern of epilepsy in India. Epilepsia 40(5):631\u2013636","journal-title":"Epilepsia"},{"key":"1311_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","volume":"25","author":"SI Johannessen","year":"2003","unstructured":"Johannessen SI, Battino D, Berry DJ et al (2003) Therapeutic drug monitoring of newer anti-epileptic drugs. Ther Drug Monit 25:347","journal-title":"Ther Drug Monit"},{"issue":"10","key":"1311_CR21","first-page":"599","volume":"60","author":"S Mallayasamy","year":"2010","unstructured":"Mallayasamy S, Arumugam K, Jain T, Rajakannan T, Bhat K, Rao PGM, Devarakonda R (2010) A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: application to plasma\u2014saliva correlation in epileptic patients. Arzneimittelforschung 60(10):599\u2013606","journal-title":"Arzneimittelforschung"},{"key":"1311_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","volume":"18","author":"JA Messenheimer","year":"1998","unstructured":"Messenheimer JA, Mullens EL, Giorgi L (1998) Safety review of adult clinical trial experience with lamotrigine. Drug Saf 18:281\u2013296","journal-title":"Drug Saf"},{"key":"1311_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10928-005-0034-2","volume":"32","author":"S Duffull","year":"2005","unstructured":"Duffull S, Waterhouse T, Eccleston J (2005) Some considerations on the design of population pharmacokinetic studies. J Pharmacokinet Pharmacodyn 32:441\u2013457","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"1311_CR24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1742-7843.2009.00533.x","volume":"106","author":"L Aarons","year":"2010","unstructured":"Aarons L, Ogungbenro K (2010) Optimal design of pharmacokinetic studies. Basic Clin Pharmacol Toxicol 106(3):250\u2013255","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"1311_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/clpt.2010.114","volume":"88","author":"N Holford","year":"2010","unstructured":"Holford N, Ma SC, Ploeger BA (2010) Clinical trial simulation: a review. Clin Pharmacol Ther 88(2):166\u2013182","journal-title":"Clin Pharmacol Ther"},{"key":"1311_CR26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199550040-00008","volume":"50","author":"A Fitton","year":"1995","unstructured":"Fitton A, Goa K (1995) Lamotrigine: an update of its pharmacology and therapeutic use in epilepsy. Drugs 50:691\u2013713","journal-title":"Drugs"},{"key":"1311_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","volume":"46","author":"GM Raymond","year":"1998","unstructured":"Raymond GM, Andrew BB, Anne LH, Andrew BB, Bennedetta CS (1998) Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 46:547\u2013551","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1311-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1311-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:03:07Z","timestamp":1642705387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1311-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1311-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,2]]}}}